Skip to main content

Advertisement

Table 4 Participant characteristics and study details of included studies

From: The feasibility, acceptability and outcomes of exergaming among individuals with cancer: a systematic review

Author (Date) Study Design Population: n enrolled, n completed/relevant (gender), mean age (range), location Disease (Severity/Stage) Timing of Intervention Delivery Setting
Betker, et al. [49] Single subject case-study 3, 1 (male), 20 (NS), Canada Cerebellar tumour (Severe ataxia) NS Hospital
Hoffman, et al. [44, 45] Feasibility study 9, 7 (2 male), 64.6 (53–73), USA Lung cancer (Stage 1A = 1, 1B = 1, 2A = 1, 2B = 2, 3A = 2) Pre-surgery, post-surgery, weekly follow-ups for 16 weeks. Home
House, et al. [47] Feasibility study 12, 6 (0 male), 57.8 (22–78), USA Breast cancer (NS) 9.5 years post-surgery Clinical Laboratory
Jahn, et al. [26] Exploratory study with qualitative evaluation. 11, 7 (5 male), 56.6 (47–70), Germany 1 = Rectal cancer, 1 = Brain metastases & breast cancer, 1 = Oesophageal cancer, 1 = Tongue cancer, 3 = Lung cancer (NS) Receiving treatment for current cancer diagnosis Hospital
Sajid, et al. [46] Randomised three-arm pilot study 31, 19 up to 6 weeks (19 male), 13 after 6 weeks. Wii Group = 8 (n-3 after 6 weeks), 77.5 (70–87). EXCAP group = 6 (n-1 after 6 weeks), 75.7 (67–93). Usual Care = 5 (n-2 after 6 weeks), 71.8 (67–80). USA Prostate cancer (NS) 62 month after initial ADT Home
Tsuda, et al. [48] Feasibility study 16, 9 (6 male), 67.4 (61–76), Japan 6 = Leukaemia, 3 = Lymphoma (NS) Receiving treatment for current cancer diagnosis Hospital
Yoon, et al. [20] Controlled study 47, 40 (17 male). IREX group = 20 (9 male), 48.6 (NS). COT = 20 (8 male), 50 (NS). South Korea Brain tumour (NS) 9 month after diagnosis NS
  1. NS Not specified, EXCAP Home-based walking and resistance intervention, ADT Androgen deprivation therapy, IREX Interactive Rehabilitation and Exercise, COT Conventional occupational therapy